HUN

Huntsman Corporation 2025 Annual Report (10-K) Summary

Business Context and Reporting Period

This summary covers the Annual Report on Form 10-K for Huntsman Corporation and its wholly-owned subsidiary, Huntsman International LLC, for the fiscal year ended December 31, 2025. Huntsman is a global manufacturer of diversified organic chemical products operating in three segments: Polyurethanes, Performance Products, and Advanced Materials. The company markets products to industrial and building product manufacturers for applications in construction, automotive, aerospace, and consumer goods.

Key Financial Metrics (Year Ended Dec 31, 2025)

Material Changes vs. Prior Period

• Revenue Decline: Revenues decreased 6% primarily due to lower average selling prices across all segments and lower sales volumes in Performance Products and Advanced Materials. The Polyurethanes segment saw a 5% revenue decline driven by less favorable supply/demand dynamics for MDI.
• Restructuring Costs: Restructuring, impairment, and plant closing costs surged to $148 million in 2025 (up from $39 million in 2024). This included significant charges for the closure of the Moers, Germany maleic anhydride facility and organizational realignments in Europe.
• Legal Settlement Income: The company recognized approximately $33 million in net income related to a litigation matter against Praxair/Linde, which partially offset operating losses.
• Equity Earnings: Equity in income of unconsolidated affiliates dropped significantly to $4 million from $44 million in 2024, largely due to decreased income at the PO/MTBE joint venture in China.
• Dividend Reduction: The Board declared a quarterly cash dividend of $0.0875 per share in Q4 2025, representing a 65% decrease from the previous dividend rate.

Guidance, Outlook, and Risks

• Liquidity Position: As of December 31, 2025, the company held $429 million in cash and had $854 million in availability under its revolving credit facility, totaling $1.323 billion in combined cash and unused borrowing capacity.
• Capital Expenditures: The company expects 2026 capital expenditures to approximate 2025 levels ($173 million), focusing on EHS upgrades, facility expansions, and cost reduction projects.
• Debt Refinancing: On February 9, 2026, Huntsman International entered into a new $800 million secured revolving credit facility (maturing 2031) to replace the 2022 facility.
• Key Risks:
  • Regulatory: Increasing global regulations on greenhouse gas emissions (EU ETS, CBAM) and climate disclosure (California S.B. 253/261) may increase operational costs.
  • Market Volatility: The chemical industry remains cyclical; demand is sensitive to global economic conditions, particularly in construction and automotive sectors.
  • Raw Materials: Exposure to volatile prices for benzene, natural gas, and other feedstocks, with limited ability to pass costs to customers immediately.
  • Valuation Allowances: The company established significant deferred tax asset valuation allowances ($85 million increase in 2025) due to cumulative losses in certain jurisdictions, impacting the effective tax rate.

Investor Verification Checklist

• Restructuring Execution: Verify the timeline and cost savings realization from the European restructuring programs and the Moers facility closure.
• MDI Market Dynamics: Monitor global MDI supply/demand balances and pricing trends, as this is the primary revenue driver for the largest segment.
• Debt Covenant Compliance: Confirm ongoing compliance with leverage ratios and other covenants under the new 2026 Revolving Credit Facility.
• Tax Valuation Allowances: Assess the likelihood of releasing deferred tax asset valuation allowances in key jurisdictions (e.g., Luxembourg, Germany) as profitability improves.
• Joint Venture Performance: Review the financial performance of the PO/MTBE joint venture in China, given the sharp decline in equity earnings.